Reducing the risk of cervical cancer in young females

Published on: Monday, 01-September-2014

The human papillomavirus vaccination (HPV) that protects girls aged between 12 to 14 years against cervical cancer is changing from September 2014. The number of doses of HPV vaccine is being reduced from three to two.

This change to the programme follows a recommendation of the national advisory body The Joint Committee on Vaccination and Immunisation, based on recent research showing that two doses provided the same protection as a three-dose course.

This change will not affect girls who have had their first dose of HPV by the age of 15 as they will continue to be offered the three-doses.

It is recommended that all girls from the age of 12 years up to their 18th birthday have the HPV vaccination as it protects them against the two main types of the virus, reducing their risk of getting cervical cancer by over 70%.

The vaccine, however, does not protect individuals against all of the other types of HPV, so they will still need to have cervical screening when they are older.

For further information, contact your GP or visit